CY1110182T1 - Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων - Google Patents
Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιωνInfo
- Publication number
- CY1110182T1 CY1110182T1 CY20101100628T CY101100628T CY1110182T1 CY 1110182 T1 CY1110182 T1 CY 1110182T1 CY 20101100628 T CY20101100628 T CY 20101100628T CY 101100628 T CY101100628 T CY 101100628T CY 1110182 T1 CY1110182 T1 CY 1110182T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ideenonon
- treatment
- muscle dystrophy
- treating
- muscular dystrophy
- Prior art date
Links
- 210000003205 muscle Anatomy 0.000 title 1
- 201000006938 muscular dystrophy Diseases 0.000 abstract 2
- 208000031229 Cardiomyopathies Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 abstract 1
- 229960004135 idebenone Drugs 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05006137 | 2005-03-21 | ||
| EP06723554A EP1861080B1 (en) | 2005-03-21 | 2006-03-20 | Idebenone for the treatment of muscular dystrophies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110182T1 true CY1110182T1 (el) | 2015-01-14 |
Family
ID=36572153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100628T CY1110182T1 (el) | 2005-03-21 | 2010-07-06 | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7977388B2 (https=) |
| EP (1) | EP1861080B1 (https=) |
| JP (1) | JP4896123B2 (https=) |
| AT (1) | ATE468849T1 (https=) |
| AU (1) | AU2006226623B2 (https=) |
| CA (1) | CA2602290C (https=) |
| CY (1) | CY1110182T1 (https=) |
| DE (1) | DE602006014514D1 (https=) |
| DK (1) | DK1861080T3 (https=) |
| ES (1) | ES2345353T3 (https=) |
| MX (1) | MX2007011571A (https=) |
| NZ (1) | NZ561235A (https=) |
| PL (1) | PL1861080T3 (https=) |
| PT (1) | PT1861080E (https=) |
| SI (1) | SI1861080T1 (https=) |
| WO (1) | WO2006100017A1 (https=) |
| ZA (1) | ZA200707833B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271935A (zh) | 2006-08-01 | 2013-09-04 | 普里克萨斯医药股份有限公司 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| EP1891946A1 (en) * | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| WO2009079562A2 (en) | 2007-12-17 | 2009-06-25 | The Regents Of The University Of Michigan | Compositions and methods for treating and preventing skeletal muscle deficiencies |
| SI2108366T1 (sl) * | 2008-04-09 | 2012-01-31 | Santhera Pharmaceuticals Ch | Idebenon za zdravljenje respiratorne bolezni pri miĺ iäśni distrofiji |
| EP2246048A1 (en) | 2009-04-30 | 2010-11-03 | Santhera Pharmaceuticals (Schweiz) AG | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis |
| DK2605769T3 (en) | 2010-08-16 | 2016-10-24 | Santhera Pharmaceuticals (Schweiz) Ag | Benzoquinonderivater for the treatment of mitochondrial diseases of the eye |
| CN103086861B (zh) * | 2012-11-12 | 2015-09-16 | 刘炜 | 羟癸基苯醌衍生物及其用途 |
| US20230047313A1 (en) * | 2019-12-16 | 2023-02-16 | Children`S Medical Center Corporation | Treating heart disease in muscular dystrophy patients |
| EP4351545A1 (en) | 2021-06-07 | 2024-04-17 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
| CN113827585B (zh) * | 2021-10-27 | 2023-04-11 | 山东大学齐鲁医院 | 艾地苯在治疗肢带型肌营养不良2g型中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8562998A (en) | 1997-08-12 | 1999-03-01 | Takeda Chemical Industries Ltd. | Idebenone-containing preparation for percutaneous administration |
| JPH11116470A (ja) | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
| US20030013772A1 (en) * | 2000-02-23 | 2003-01-16 | Murphy Michael A. | Composition, synthesis and therapeutic applications of polyamines |
| CA2272971C (en) | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
| US20040081961A1 (en) * | 2001-05-04 | 2004-04-29 | Delegeane Angelo M | Proteases |
| EP1618881A1 (en) | 2004-07-20 | 2006-01-25 | Santhera Pharmaceuticals (Schweiz) GmbH | Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
-
2006
- 2006-03-20 SI SI200630706T patent/SI1861080T1/sl unknown
- 2006-03-20 MX MX2007011571A patent/MX2007011571A/es active IP Right Grant
- 2006-03-20 JP JP2008502302A patent/JP4896123B2/ja not_active Expired - Fee Related
- 2006-03-20 PT PT06723554T patent/PT1861080E/pt unknown
- 2006-03-20 WO PCT/EP2006/002536 patent/WO2006100017A1/en not_active Ceased
- 2006-03-20 US US11/886,388 patent/US7977388B2/en not_active Expired - Fee Related
- 2006-03-20 ES ES06723554T patent/ES2345353T3/es not_active Expired - Lifetime
- 2006-03-20 CA CA2602290A patent/CA2602290C/en not_active Expired - Fee Related
- 2006-03-20 DK DK06723554.9T patent/DK1861080T3/da active
- 2006-03-20 NZ NZ561235A patent/NZ561235A/en not_active IP Right Cessation
- 2006-03-20 AT AT06723554T patent/ATE468849T1/de active
- 2006-03-20 EP EP06723554A patent/EP1861080B1/en not_active Expired - Lifetime
- 2006-03-20 PL PL06723554T patent/PL1861080T3/pl unknown
- 2006-03-20 AU AU2006226623A patent/AU2006226623B2/en not_active Ceased
- 2006-03-20 DE DE602006014514T patent/DE602006014514D1/de not_active Expired - Lifetime
-
2007
- 2007-09-13 ZA ZA200707833A patent/ZA200707833B/xx unknown
-
2010
- 2010-07-06 CY CY20101100628T patent/CY1110182T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006014514D1 (https=) | 2010-07-08 |
| AU2006226623B2 (en) | 2010-04-22 |
| WO2006100017A1 (en) | 2006-09-28 |
| PL1861080T3 (pl) | 2010-10-29 |
| ATE468849T1 (de) | 2010-06-15 |
| PT1861080E (pt) | 2010-06-17 |
| SI1861080T1 (sl) | 2010-08-31 |
| MX2007011571A (es) | 2007-12-06 |
| JP2008533182A (ja) | 2008-08-21 |
| US20090012050A1 (en) | 2009-01-08 |
| EP1861080B1 (en) | 2010-05-26 |
| US7977388B2 (en) | 2011-07-12 |
| NZ561235A (en) | 2010-12-24 |
| EP1861080A1 (en) | 2007-12-05 |
| CA2602290A1 (en) | 2006-09-28 |
| DK1861080T3 (da) | 2010-09-06 |
| ES2345353T3 (es) | 2010-09-21 |
| JP4896123B2 (ja) | 2012-03-14 |
| AU2006226623A1 (en) | 2006-09-28 |
| CA2602290C (en) | 2012-01-17 |
| ZA200707833B (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| IL196965A (en) | Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure | |
| CR8012A (es) | Clavo endomedular destinado al tratamiento de fracturas de femur proximal | |
| EP1991218A4 (en) | USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES | |
| CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
| WO2006113802A3 (en) | Device for administering electrode stimulation of back and abdominal muscles | |
| PT2083837E (pt) | Utilização terapêutica de pelo menos uma neurotoxina botulínica no tratamento da dor induzida por, pelo menos, um agente anti-cancerígeno | |
| BRPI0911203A2 (pt) | peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo. | |
| EP1786311A4 (en) | VOLUMETRIC POINT BROADING FUNCTION FOR EYE DIAGNOSIS AND TREATMENT | |
| PL1912650T3 (pl) | Zastosowanie flibanseryny w leczeniu otyłości | |
| ZA200711105B (en) | Novel physiological substance nesfatin substance relevant thereto, and use of the substances | |
| ZA200703441B (en) | Coadministration of tigecycline and digoxin | |
| WO2009027703A3 (en) | Identifying organ damage | |
| EP2716285A3 (en) | New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss | |
| UA88655C2 (ru) | S-миртазапин для лечения прилива крови | |
| NL1027109A1 (nl) | Verbinding en gebruik bij behandeling. | |
| MX2009008873A (es) | Composicion util para el tratamiento de diabetes tipo 2. | |
| ZA200900938B (en) | Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure | |
| IL178190A0 (en) | Medical plaster for application on the skin | |
| MX2007004040A (es) | Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. | |
| WO2007012066A3 (en) | TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF | |
| PL1937245T3 (pl) | Związek użyteczny w zapobieganiu i leczeniu przerostu lewej komory u pacjentów dializowanych | |
| AR051035A1 (es) | Uso de epotilonas en el tratamiento de metastasis en hueso | |
| HK1153406A (en) | Piperlongumine and piperlongumine analogs for use in the treatment of cancer |